-
Signature
-
/s/ Chanda Kirchner, Attorney-in-Fact for Karen J. Holcom
-
Issuer symbol
-
AYI
-
Transactions as of
-
28 Jan 2026
-
Net transactions value
-
-$1,323,045
-
Form type
-
4
-
Filing time
-
30 Jan 2026, 16:02:35 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| HOLCOM KAREN J |
SVP & Chief Financial Officer |
C/O ACUITY INC., 1170 PEACHTREE STREET, NE, SUITE 1200, ATLANTA |
/s/ Chanda Kirchner, Attorney-in-Fact for Karen J. Holcom |
30 Jan 2026 |
0001302261 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AYI |
Common Stock |
Options Exercise |
$215,065 |
+897 |
+3.5% |
$239.76 |
26,497 |
28 Jan 2026 |
Direct |
F1 |
| transaction |
AYI |
Common Stock |
Sale |
$1,538,110 |
-4,974 |
-19% |
$309.23 |
21,523 |
28 Jan 2026 |
Direct |
F1 |
| holding |
AYI |
Common Stock |
|
|
|
|
|
302 |
28 Jan 2026 |
By 401(k) Plan |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AYI |
Non-Qualified Stock Option |
Options Exercise |
$0 |
-897 |
-100% |
$0.000000 |
0 |
28 Jan 2026 |
Common Stock |
897 |
$239.76 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: